N-palmitoyl-ethanolamine: Biochemistry and new therapeutic opportunities.
about
Treatment of chronic regional pain syndrome type 1 with palmitoylethanolamide and topical ketamine cream: modulation of nonneuronal cells.Transcriptomics: A Step behind the Comprehension of the Polygenic Influence on Oxidative Stress, Immune Deregulation, and Mitochondrial Dysfunction in Chronic Kidney DiseaseGlial Modulation by N-acylethanolamides in Brain Injury and NeurodegenerationAdvances in the discovery of N-acylethanolamine acid amidase inhibitors"Redundancy" of endocannabinoid inactivation: new challenges and opportunities for pain controlAlkyne lipids as substrates for click chemistry-based in vitro enzymatic assaysPalmitoylethanolamide counteracts reactive astrogliosis induced by β-amyloid peptideThe pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations.Effect of dietary krill oil supplementation on the endocannabinoidome of metabolically relevant tissues from high-fat-fed mice.Peripheral gating of pain signals by endogenous lipid mediators.Synthesis and structure-activity relationships of N-(2-oxo-3-oxetanyl)amides as N-acylethanolamine-hydrolyzing acid amidase inhibitors.The association of N-palmitoylethanolamine with the FAAH inhibitor URB597 impairs melanoma growth through a supra-additive action.Metabolism of endocannabinoids and related N-acylethanolamines: canonical and alternative pathways.Identification of prostamides, fatty acyl ethanolamines, and their biosynthetic precursors in rabbit cornea.Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes.Palmitoylethanolamide, a naturally occurring lipid, is an orally effective intestinal anti-inflammatory agent.Dietary triacylglycerols with palmitic acid in the sn-2 position modulate levels of N-acylethanolamides in rat tissuesCo-ultramicronized Palmitoylethanolamide/Luteolin Promotes the Maturation of Oligodendrocyte Precursor CellsAnti-Inflammatory, Antioxidant and Crystallographic Studies of N-Palmitoyl-ethanol Amine (PEA) Derivatives.Mast cell-glia axis in neuroinflammation and therapeutic potential of the anandamide congener palmitoylethanolamide.Palmitoylethanolamide in Fibromyalgia: Results from Prospective and Retrospective Observational Studies.Effect of a new formulation of micronized and ultramicronized N-palmitoylethanolamine in a tibia fracture mouse model of complex regional pain syndromeNutritional properties of dietary omega-3-enriched phospholipids.A pro-nociceptive phenotype unmasked in mice lacking fatty-acid amide hydrolaseThe anti-inflammatory mediator palmitoylethanolamide enhances the levels of 2-arachidonoyl-glycerol and potentiates its actions at TRPV1 cation channels.Warfarin untargeted metabolomics study identifies novel procoagulant ethanolamide plasma lipids.Glia and mast cells as targets for palmitoylethanolamide, an anti-inflammatory and neuroprotective lipid mediator.Palmitoylethanolamide, a naturally occurring disease-modifying agent in neuropathic pain.Micronized palmitoylethanolamide reduces the symptoms of neuropathic pain in diabetic patientsA novel crosstalk within the endocannabinoid system controls GABA transmission in the striatum.Micronized/ultramicronized palmitoylethanolamide displays superior oral efficacy compared to nonmicronized palmitoylethanolamide in a rat model of inflammatory pain.Palmitoylethanolamide controls reactive gliosis and exerts neuroprotective functions in a rat model of Alzheimer's disease.Palmitoylethanolamide stimulates phagocytosis of Escherichia coli K1 by macrophages and increases the resistance of mice against infections.The beneficial use of ultramicronized palmitoylethanolamide as add-on therapy to Tapentadol in the treatment of low back pain: a pilot study comparing prospective and retrospective observational arms.Co-Ultramicronized Palmitoylethanolamide/Luteolin Facilitates the Development of Differentiating and Undifferentiated Rat Oligodendrocyte Progenitor Cells.Palmitoylethanolamide Ameliorates Hippocampal Damage and Behavioral Dysfunction After Perinatal Asphyxia in the Immature Rat Brain.Innovative Nanoparticles Enhance N-Palmitoylethanolamide Intraocular Delivery.Topical cannabinoid receptor 1 agonist attenuates the cutaneous inflammatory responses in oxazolone-induced atopic dermatitis model.Minor Plasma Lipids Modulate Clotting Factor Activities and May Affect Thrombosis Risk.
P2860
Q24630453-81E0FF12-BAE1-4207-B52B-D0589A858951Q26740125-E9335C96-E872-4208-9FD3-C93B8AC7463AQ26747533-C619B090-D212-449D-A66C-C2D17BF4232FQ26866274-7D2ED3A0-A212-4BBA-B3BA-C77E3492A2EBQ27015753-03DFEA1C-B4C5-490E-BCED-54261143F19DQ28385488-942053C7-3F4A-46E4-AFB3-A1D25216E456Q28390536-A3891A4D-2400-4648-A5FA-22C86954856DQ31122398-9791A64B-FFCA-46AF-A9B8-14FCF92558FEQ33451202-7CE5D5D1-5A70-4491-9972-2236A420466DQ33608432-02754A27-3422-46F0-BA0A-70C8AC7CE1EEQ34101852-9F477A93-5EEB-45FA-B026-9C13822AB49DQ34202076-952534D5-21AC-4358-A945-FF4B097258F1Q34328745-5CE8847E-168E-457B-99FB-1FA1F72E75E2Q34478780-3979024F-8815-4EB3-9E80-9DC2EE16D781Q34625932-AD679007-8401-4EDC-9258-464EAFCBAF31Q34795735-CEEE7C2D-11E6-4A56-B1F0-710442C404ACQ35578640-5B3DA1BF-114B-4AC5-86CA-A8F3BE17ED84Q36290946-5F601A38-EA90-4641-8FFB-F68A2A24C5A3Q36343053-55B232EC-951A-4723-8136-AEBA671421FBQ36348374-95F513FA-A211-4F9D-A935-41A7B8FA11F4Q36365821-B2F54F72-3477-4576-8ECB-94D79C293E62Q36395889-D0F81544-C848-4F53-8B26-275E65094116Q37105403-613A0D9B-C506-481C-B876-46A3D9E83847Q37115263-CA10EC8C-ABB7-4A65-8FC4-D3DB02D7FB07Q37682000-78928A52-3F5C-429F-9DB8-458C4BE856ADQ37699506-28CDCCB4-AAAF-4686-8946-F6BD53AF5900Q38118187-DB41C11F-CD9A-41E3-BEAC-63E0F8ACCF6CQ38157791-33522EA1-2558-4A48-B9E1-6CC2D945CA6AQ38908402-67A9EF15-4DB5-477E-B191-4434996646D9Q41260178-B3680E7F-22FF-4B04-BB95-79CA3E785CEAQ42176106-0B714405-A8CD-4761-AD54-5131FFB63664Q42580206-5B0E8537-77B4-40E1-A808-ACA931D981F8Q42719351-2A89381C-D549-42DA-8832-D04FDE0E39C0Q47127221-C56E31E5-1C38-40E0-ABCA-322C22E402C2Q47932285-A7C96DC1-9B3C-460F-BAFA-FBA91EE536ACQ52584461-86C342D3-A6F5-4432-A17C-E00A5957EEE8Q52592946-E419BF86-B7A8-4E7B-A708-52A2610A58EFQ53211337-6FE009D4-6DA7-4662-902B-8250EFEA6019Q55359034-83CA5C77-6399-4024-94C1-9EC65E8598E3
P2860
N-palmitoyl-ethanolamine: Biochemistry and new therapeutic opportunities.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
N-palmitoyl-ethanolamine: Biochemistry and new therapeutic opportunities.
@ast
N-palmitoyl-ethanolamine: Biochemistry and new therapeutic opportunities.
@en
N-palmitoyl-ethanolamine: Biochemistry and new therapeutic opportunities.
@nl
type
label
N-palmitoyl-ethanolamine: Biochemistry and new therapeutic opportunities.
@ast
N-palmitoyl-ethanolamine: Biochemistry and new therapeutic opportunities.
@en
N-palmitoyl-ethanolamine: Biochemistry and new therapeutic opportunities.
@nl
prefLabel
N-palmitoyl-ethanolamine: Biochemistry and new therapeutic opportunities.
@ast
N-palmitoyl-ethanolamine: Biochemistry and new therapeutic opportunities.
@en
N-palmitoyl-ethanolamine: Biochemistry and new therapeutic opportunities.
@nl
P1433
P1476
N-palmitoyl-ethanolamine: Biochemistry and new therapeutic opportunities.
@en
P2093
Stefania Petrosino
Teresa Iuvone
P304
P356
10.1016/J.BIOCHI.2010.01.006
P577
2010-01-21T00:00:00Z